Ebos
Ebos Group Limited, commonly referred to as Ebos, is a leading healthcare and pharmaceutical company headquartered in Australia. Established in 1922, Ebos has grown to become a prominent player in the industry, with significant operations across New Zealand and Australia. The company focuses on the distribution of medical supplies, pharmaceuticals, and healthcare products, catering to hospitals, pharmacies, and aged care facilities. Ebos is renowned for its extensive product range, which includes medical consumables, surgical instruments, and pharmacy services, all distinguished by their quality and reliability. With a strong market position, Ebos has achieved notable milestones, including strategic acquisitions that have expanded its reach and capabilities. As a trusted partner in the healthcare sector, Ebos continues to innovate and adapt, ensuring it meets the evolving needs of its customers.
DitchCarbon Score
How does Ebos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ebos's score of 18 is higher than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ebos's reported carbon emissions
In 2023, Ebos reported significant carbon emissions, totalling approximately 2,984,000 kg CO2e from Scope 1 and 16,993,000 kg CO2e from Scope 2 globally. In Australia, their emissions included about 2,680,000 kg CO2e from Scope 1 and 16,153,000 kg CO2e from Scope 2. The company has shown a slight increase in Scope 1 emissions from 2,741,000 kg CO2e in 2022 to 2,984,000 kg CO2e in 2023, while Scope 2 emissions remained relatively stable. Ebos has not disclosed specific reduction targets or initiatives as part of their climate commitments, indicating a lack of formalised strategies such as Science-Based Targets Initiative (SBTi) targets or documented reduction initiatives. This absence suggests that while the company is aware of its emissions, it may not yet have established comprehensive plans to mitigate its carbon footprint effectively. Overall, Ebos's emissions data highlights the need for enhanced climate action and transparency in their sustainability efforts, particularly in the context of increasing global scrutiny on corporate environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 740,400 | 000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 14,545,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ebos is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
